HCT/P TRACKING

Implant tissue traceability software that closes the loop from donor to recipient and back

Implant tissue traceability is the record that lets a hospital or tissue bank follow a human cell or tissue product in both directions: donor to consignee or final disposition, and consignee back to the donor. FDA requires that system under 21 CFR 1271.290, built on a distinct identification code that may not contain a name, a social security number or a medical record number. Neurobird holds that code and its history.

21 CFR 1271.290tracking requirement
2 directionsdonor and consignee
1271.55records that must accompany
Tissue coordinator scanning an allograft package label against a storage log in a hospital tissue store, used to illustrate where a distinct identification code enters the traceability record
Where the trace is really made or lost: the moment the code is read into the record.

Neurobird Implant Tissue Traceability in short

  • Hold the distinct identification code as the primary key, without a name or a medical record number in it
  • Record disposition for every unit, including product that was discarded rather than implanted
  • Relate a new code to an old code when a product is reassigned, as the rule requires
  • 21 CFR 1271.290 Requires a tracking system that follows every HCT/P from the donor to the consignee or final disposition, and from the consignee back to the donor. eCFR, 21 CFR 1271.290
  • 1 code A distinct identification code must be created specifically for tracking, and it may not include an individual's name, social security number or medical record number. eCFR, 21 CFR 1271.290
  • Pricing runs 450 to 2400 US dollars per month across 3 tiers. Early access is free.
The daily reality

What tissue banks and hospital tissue programmes actually deal with

The distinct identification code is recorded in three systems and only one of them is the one an inspector asks for.
A recall arrives naming a donor and the search for every affected recipient starts with a phone call.
Tissue arrives with paperwork that gets filed, so the link between the graft and the patient lives in a chart note.

Why it stays broken

Tissue crosses a supplier, a storage location, an operating room and a patient chart, and each of those has its own system. None of them owns the identification code end to end. So traceability exists as four partial records that a person reconciles under pressure, which is exactly when it needs to be instant.

FDA requires tracking from the donor to the consignee or final disposition, and from the consignee back to the donor.

As part of your tracking system, you must establish and maintain a method for documenting the disposition of each of your HCT/Ps, to enable tracking from the donor to the consignee or final disposition.

law.cornell.edu, source
Interactive preview

The trace, as your coordinator would run it

Tick a unit to record its disposition and watch the donor and consignee trace resolve.

neurobird / tissue trace
0 of 4 graft inspected

Tap an asset to log a scan and timestamp the inspection.

What it does

Neurobird Implant Tissue Traceability Inspection Tracking Platform

One record per graft, keyed on the distinct identification code: where it came from, where it was stored, who received it and what happened to anything not used. It answers a recall in one direction or the other.

  • 1Hold the distinct identification code as the primary key, without a name or a medical record number in it
  • 2Record disposition for every unit, including product that was discarded rather than implanted
  • 3Relate a new code to an old code when a product is reassigned, as the rule requires
  • 4Produce the accompanying records for an audit without assembling them from four systems

What changes with Neurobird Implant Tissue Traceability?

The same work, read left to right: how it runs today, and how it runs once the record is in one place.

Implant tissue traceability: current practice compared with Neurobird Implant Tissue Traceability
TodayWith Neurobird Implant Tissue Traceability
The distinct identification code is recorded in three systems and only one of them is the one an inspector asks forHold the distinct identification code as the primary key, without a name or a medical record number in it
A recall arrives naming a donor and the search for every affected recipient starts with a phone callRecord disposition for every unit, including product that was discarded rather than implanted
Tissue arrives with paperwork that gets filed, so the link between the graft and the patient lives in a chart noteRelate a new code to an old code when a product is reassigned, as the rule requires

Who is this for?

The same identification code, three different obligations.

Hospital programme

You implant what others supply

You need the graft tied to the patient and the disposition of everything you did not use, in a form an inspector recognises.

Tissue bank

You distribute to consignees

You need to identify the consignee of any unit promptly, which is the specific thing the rule asks for.

Multi site system

You store in several places

A unit moves between sites before it is used. The trace has to survive the move rather than restart at each one.

How does Neurobird Implant Tissue Traceability work?

  1. Receive on the code

    Every unit is booked in against its distinct identification code and the records that must accompany it, so the tracking key exists before the tissue is stored.

  2. Follow it to disposition

    Storage, issue, implant or discard are all disposition events against the same unit, which is what makes the trace work in both directions.

  3. Answer a recall in minutes

    A donor identifier resolves to every unit and every consignee, and a consignee resolves back to the donor, without a phone tree.

What the tracking rule actually requires

The federal requirements a tissue traceability system is measured against.

21 CFR 1271.290

Requires a tracking system that follows every HCT/P from the donor to the consignee or final disposition, and from the consignee back to the donor.

eCFR, 21 CFR 1271.290
1 code

A distinct identification code must be created specifically for tracking, and it may not include an individual's name, social security number or medical record number.

eCFR, 21 CFR 1271.290
1271.55

Sets out which records must accompany an HCT/P after the donor eligibility determination, and requires that they carry no information identifying the donor.

eCFR, 21 CFR 1271.55
2 links

Where a new code is assigned to a product, procedures must relate the new code to the old one, so the chain does not break at reassignment.

eCFR, 21 CFR 1271.290
820.65

The device quality system rule on traceability, which applies where an implant is a device rather than a tissue product.

eCFR, 21 CFR 820.65

Implant tissue traceability software questions, answered

Key terms

What is implant tissue traceability?
It is the ability to follow a human cell or tissue product in both directions: from the donor to whoever received it or to its final disposition, and from that consignee back to the donor. FDA requires a system that does this under 21 CFR 1271.290, keyed on a distinct identification code.
What is a distinct identification code?
It is the tracking key assigned to a product specifically for tracking. The rule is explicit that it may not include an individual's name, social security number or medical record number, so it cannot simply be a patient or donor identifier reused.

Does this replace our electronic health record?

No. The chart records the clinical event. This records the unit: where it came from, where it was held, what happened to it, and the code that ties those together. The two reference each other.

What happens when a product is reassigned a new code?

The rule requires procedures relating the new code to the old one. The system keeps both and the link between them, so a recall against an old code still resolves.

Why we are building this

T

h

e

r

u

l

e

h

e

r

e

i

s

u

n

u

s

u

a

l

l

y

c

l

e

a

r

a

b

o

u

t

w

h

a

t

a

s

y

s

t

e

m

h

a

s

t

o

d

o

,

a

n

d

u

n

u

s

u

a

l

l

y

q

u

i

e

t

a

b

o

u

t

h

o

w

.

T

w

o

d

i

r

e

c

t

i

o

n

a

l

t

r

a

c

k

i

n

g

o

n

a

c

o

d

e

t

h

a

t

c

a

n

n

o

t

c

o

n

t

a

i

n

a

n

a

m

e

i

s

a

d

a

t

a

b

a

s

e

p

r

o

b

l

e

m

w

i

t

h

a

p

a

t

i

e

n

t

s

a

f

e

t

y

c

o

n

s

e

q

u

e

n

c

e

,

a

n

d

i

t

i

s

s

t

i

l

l

b

e

i

n

g

s

o

l

v

e

d

w

i

t

h

b

i

n

d

e

r

s

i

n

a

l

o

t

o

f

p

l

a

c

e

s

.

T

h

e

r

e

g

u

l

a

t

i

o

n

s

w

e

b

u

i

l

t

t

o

a

r

e

l

i

n

k

e

d

a

b

o

v

e

s

o

y

o

u

c

a

n

c

h

e

c

k

o

u

r

r

e

a

d

i

n

g

o

f

t

h

e

m

r

a

t

h

e

r

t

h

a

n

t

r

u

s

t

i

t

.

Neurobird Team neurobird.com

Where the requirement comes from

Primary sources, straight from the regulators.

How much does Neurobird Implant Tissue Traceability cost?

Priced per site because storage, procedure and the inspection that follows are site level things. Units, codes and users are unlimited on every tier.

Single site
$450
per month
  • One facility
  • Unlimited units and codes
  • Two directional trace
  • Disposition log
Request early access
Programme
$1,100
per month
  • Multi department
  • Recall resolution view
  • Accompanying records vault
  • Inspection export
Request early access
System
$2,400
per month
  • Unlimited sites
  • Inter site transfers
  • Supplier integrations
  • Priority support
Request early access
Opening 6 early access places for tissue programmes.

Get free early access

Early access means we model your product types and supplier record formats before you enter anything, and you keep the account free while we do it.

Straight answer on where this is: The software is in development. Nothing is purchasable today. Early access means you shape it and pay nothing while we build.

Prefer email? Write to office@neurobird.com and a person will reply. No autoresponder.